deWiz AB Closes Out Series-B Funding to Fuel Golf Wearable Technology Business
deWiz AB has closed out its current Series-B funding round with more than 43 million SEK (nearly 4M USD) in new investment dedicated to its deWiz Golf business. The oversubscribed investment will showcase deWiz’s wearable swing modifying technology through additional marketing, further global expansion, continued product development, and added staffing to support further growth. And with financial backing secured for the golf vertical, deWiz AB can continue development on new verticals, including sports like basketball and tennis, as well as broader applications across gaming and healthcare. The Series-B funding round was backed by the original investors group, and includes new investors like Patrick Rees, founder of Bygghemma, and global deWiz ambassadors Vijay Singh and Annika Sörenstam.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221006005058/en/
deWiz Golf AB's swing modifier wearable tech, which tracks the exact position of a golfer's hands throughout the swing and provides a 3D analysis to help golfers hit the ball longer, straighter and closer more consistently. (Photo: Business Wire)
“As deWiz continues to push the boundaries of technology and learning, this latest investment round will fuel our continued global growth of our golf swing modifier, which has gained tremendous traction the past year at all levels of the golf industry, spanning instructors, professional tour players and club golfers. This investment round bolsters our deWiz golf business for the future and next we will focus on raising additional investment for further development of new applications of our patented, stimuli-based technology,” said Jesper Kärrbrink, Chairman of the Board, deWiz AB.
“Matching our Series-A funding round last year, it’s a testament of deWiz’s potential with this fundraising effort countering the global economic and geopolitical headwinds and expanding the scope of our investors group. As we continue to grow, we’re establishing a U.S.-based investment entity and opening up new markets, both for our golf technology globally, as well as new technology solutions for other sports and industries for our patented approaches within wearable tech,” said Christian Bergh, cofounder and CEO, deWiz AB.
“Part of the foundation of deWiz’s latest investment round has been the enthusiasm within the golf industry for deWiz Golf’s innovative swing data as we continue to introduce it to coaches and golfers, from the world’s elite to beginners trying to cure their slice. We’ve added a new layer of easily accessible swing data that helps golfers better understand precisely what they are doing in every swing, eliminating the guesswork and providing them tangible data points to hit the ball longer, straighter, and closer,” said Markus Westeberg, cofounder and Chief Product Officer, deWiz Golf AB.
DEWIZ GOLF, HOW IT WORKS: Under development for more than five years, deWiz tracks the exact position of a golfer's hands throughout the swing, providing a 3D analysis and delivering data via a user-friendly app that helps golfers more consistently hit the ball longer, straighter, and closer, as well as learn faster with deWiz’s patented Learning Stimuli™. To access videos on all deWiz’s groundbreaking features, instructional webinars, and ambassador testimonials, please visit deWiz’s YouTube Channel.
DEWIZ COACHES PROGRAM: The deWiz Coaches Program provides teaching professionals an innovative new approach to coaching by providing students actionable, real-time data that they can apply to their own practice, seamlessly monitoring their progress between lessons. The deWiz Coaches Program benefits include affiliate revshare programs, access to advance data and dedicated onboarding services for certified golf instructors. To learn more, visit deWiz Coaches Program or email coach@dewizgolf.com. Currently, deWiz Coaches Program has partnerships with the LPGA Professionals, PGA of Sweden, PGA of Germany and the Southern California PGA of America Section.
DEVELOPED BY EXPERTS, TESTED BY PROS: The deWiz Global Ambassadors roster currently includes Annika Sörenstam, 10-time major-champion; Vijay Singh, 3-time major-champion; Bryson DeChambeau, U.S. Open champion from 2020; 2016 Open-champion Henrik Stenson; 2021 U.S. Women’s Open champion Yuka Saso; 2019 Houston Open-champion Lanto Griffin; 2-time long drive world champion, Tim Burke, and former PGA of America National Teacher of the Year Martin Hall.
BUZZWORTHY TECH: Debuting last summer, deWiz’s introduction has created a “buzz” with it being described by Forbes as looking to bring a “jolt to the golf training aid market;” profiled in Sweden’s leading financial media, Dagens Industri; featured within On the Mark Podcast with Mark Immelman; and showcased by Global Golf Post, Golf Monthly’s Editor’s Choice, and Business Insider. Additionally, Golf.com profiled how Vijay Singh’s uses deWiz to lengthen his backswing, Annika Sörenstam’s uses deWiz to monitor her tempo and Yuka Saso uses deWiz to dial in her wedge game.
ABOUT DEWIZ AB: As a world leader in stimuli-based motor learning, deWiz enables people to unlock their potential and achieve their goals through groundbreaking data and technology. As a Swedish developed and produced product, deWiz Golf AB is focused on its mission to help golfers around the world increase their enjoyment of the game through innovative technology that increases their pace of learning. Developed in Malmö by co-founders Markus Westerberg (PGA Professional, Ljunghusen Golfklubb) and Christian Bergh, deWiz is available in the U.S., Canada, Europe, Australia, Japan, South Africa, and South Korea (more markets are opening regularly - visit the site for the latest updates). For more information on deWiz AB, visit dewiz.com for investor relations and corporate information. For ecommerce and more information on deWiz’s patented golf swing modifier, visit dewizgolf.com and learn more on how to consistently hit the ball longer, straighter, and closer. Download the free deWiz Golf demo app to explore its pioneering swing data via the Apple App Store or Google Play.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221006005058/en/
Contact information
David Schaefer
Marketing and Communications, deWiz Golf
David@dewizgolf.com
+46702877637
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com